NABI BIOPHARMACEUTICALS has a total of 112 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are IST FARMACOTERAPICO IT SPA, AUTOIMMUNE INC and LEES ANDREW.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 | |
#2 | EPO (European Patent Office) | 19 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | Argentina | 7 | |
#5 | Canada | 7 | |
#6 | China | 7 | |
#7 | Republic of Korea | 7 | |
#8 | Mexico | 7 | |
#9 | Taiwan | 5 | |
#10 | Australia | 4 | |
#11 | New Zealand | 4 | |
#12 | Japan | 3 | |
#13 | EAPO (Eurasian Patent Organization) | 2 | |
#14 | Hong Kong | 2 | |
#15 | Norway | 2 | |
#16 | Brazil | 1 | |
#17 | Hungary | 1 | |
#18 | Israel | 1 | |
#19 | Montenegro | 1 | |
#20 | Poland | 1 | |
#21 | Serbia | 1 | |
#22 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Unspecified technologies | |
#5 | Analysing materials | |
#6 | Heterocyclic compounds | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Fattom Ali Ibrahim | 40 |
#2 | Ennifar Sofiane | 28 |
#3 | Naso Robert B | 28 |
#4 | Fattom Ali | 25 |
#5 | Fattom Ali I | 23 |
#6 | Taylor Kimberly L | 15 |
#7 | Winston Scott | 13 |
#8 | Fuller Steve | 13 |
#9 | Kessler Paul | 13 |
#10 | Fahim Raafat | 13 |
Publication | Filing date | Title |
---|---|---|
US2011182918A1 | Personalized drug treatment and smoking cessation kit and method | |
WO2011014679A1 | Method and kit for treating nicotine addiction | |
CA2727617A1 | Smoking cessation kit and method | |
US2007212364A1 | Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women | |
EP1963308A2 | Method for making nicotine hapten | |
CA2611023A1 | Use of panton-valentine leukocidin for treating and preventing staphylococcus infections | |
WO2006076058A1 | Method of treating staphylococcus aureus infection | |
US2006228368A1 | Method of protecting against staphylococcal infection | |
US2006134141A1 | Glycoconjugate vaccines containing peptidoglycan | |
NZ531647A | Glycoconjugate vaccines for use in immune-compromised populations against Staphylococcal and Enterococcal infections | |
KR20080089527A | Glycoconjugate vaccines for use in immune-compromised populations | |
BR0212554A | Method of protection of immunocompromised person, use of a glycoconjugate of a polysaccharide or glycopeptide bacterial surface antigen and an immunocarrier and kit | |
US2002131969A1 | Compositions of β-glucans and specific antibodies | |
US6936258B1 | Staphylococcus antigen and vaccine |